Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
55.11
+0.90 (1.66%)
Jun 18, 2026, 4:00 PM EDT - Market closed
KNSA Market Cap
KNSA has a market cap or net worth of $4.24 billion as of June 18, 2026. Its market cap has increased by 101.20% in one year.
Market Cap
4.24B
Enterprise Value
3.78B
1-Year Change
101.20%
Ranking
Category
Stock Price
$55.11
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $4.24B, an increase of 363.70%. That is a compound annual growth rate of 20.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 4.24B | 35.61% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
| May 24, 2018 | 914.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 8.29B |
| Alkermes | 7.35B |
| Hims & Hers Health | 7.28B |
| Lantheus Holdings | 6.84B |
| Liquidia | 6.05B |
| Amneal Pharmaceuticals | 5.18B |
| Supernus Pharmaceuticals | 2.53B |
| BioCryst Pharmaceuticals | 2.27B |